newsfilter
← Latest News
GlobeNewswire·

Turning Point Therapeutics to Participate in 42nd Annual Cowen Healthcare Conference

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that President and CEO Athena Countou